Analystreport

Hepion Pharmaceuticals, Inc. (NASDAQ: HEPA) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating on the stock.

Hepion Pharmaceuticals, Inc.  (HEPA) 
Last hepion pharmaceuticals, inc. earnings: 11/14 05:17 pm Check Earnings Report